Machine Learning Approach to Understand Worsening Renal Function in Acute Heart Failure

Biomolecules. 2022 Nov 2;12(11):1616. doi: 10.3390/biom12111616.

Abstract

Acute heart failure (AHF) is a common and severe condition with a poor prognosis. Its course is often complicated by worsening renal function (WRF), exacerbating the outcome. The population of AHF patients experiencing WRF is heterogenous, and some novel possibilities for its analysis have recently emerged. Clustering is a machine learning (ML) technique that divides the population into distinct subgroups based on the similarity of cases (patients). Given that, we decided to use clustering to find subgroups inside the AHF population that differ in terms of WRF occurrence. We evaluated data from the three hundred and twelve AHF patients hospitalized in our institution who had creatinine assessed four times during hospitalization. Eighty-six variables evaluated at admission were included in the analysis. The k-medoids algorithm was used for clustering, and the quality of the procedure was judged by the Davies-Bouldin index. Three clinically and prognostically different clusters were distinguished. The groups had significantly (p = 0.004) different incidences of WRF. Inside the AHF population, we successfully discovered that three groups varied in renal prognosis. Our results provide novel insight into the AHF and WRF interplay and can be valuable for future trial construction and more tailored treatment.

Keywords: acute heart failure; artificial intelligence; cardiorenal syndrome; clustering; machine learning.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Creatinine
  • Heart Failure*
  • Humans
  • Kidney / physiology
  • Machine Learning

Substances

  • Creatinine

Grants and funding

This research and APC were funded by the European Union’s Horizon 2020 research and innovation programme, grant number 857446. Presented analyses were conducted with experts from the consortium HeartBIT_4.0—Application of Innovative Medical Data Science technologies for heart diseases.